{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:48:08Z","timestamp":1791560888375,"version":"4.3.4"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T00:00:00Z","timestamp":1461974400000},"content-version":"am","delay-in-days":242,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT), Portugal","doi-asserted-by":"publisher","award":["SFRH\/BPD\/92934\/2013"],"award-info":[{"award-number":["SFRH\/BPD\/92934\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT), Portugal","doi-asserted-by":"publisher","award":["SFRH\/BD\/96519\/2013"],"award-info":[{"award-number":["SFRH\/BD\/96519\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["VIH\/SAU\/0021\/2011"],"award-info":[{"award-number":["VIH\/SAU\/0021\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Regional Development Fund (ERDF) through the Programa Operacional Factores de Competitividade \u2013 COMPETE"},{"DOI":"10.13039\/501100001871","name":"Portuguese funds through FCT","doi-asserted-by":"publisher","award":["PEst-C\/SAU\/LA0002\/2013"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0002\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"North Portugal Regional Operational Programme"},{"name":"National Strategic Reference Framework (NSRF)","award":["SAESCTN-PIIC&DT\/2011"],"award-info":[{"award-number":["SAESCTN-PIIC&DT\/2011"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.addr.2014.12.004","type":"journal-article","created":{"date-parts":[[2014,12,27]],"date-time":"2014-12-27T11:49:06Z","timestamp":1419680946000},"page":"53-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"special_numbering":"C","title":["Polymer-based nanocarriers for vaginal drug delivery"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2317-2759","authenticated-orcid":false,"given":"Jos\u00e9","family":"das Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rute","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9347-2407","authenticated-orcid":false,"given":"Alexandra","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2014.12.004_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.addr.2014.12.004_bb0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00192-012-2009-3","article-title":"The vagina as a route for drug delivery: a review","volume":"24","author":"Srikrishna","year":"2013","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.addr.2014.12.004_bb0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/03602538308991387","article-title":"Absorption from the vagina","volume":"14","author":"Benziger","year":"1983","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0020","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0002-9378(99)70042-6","article-title":"Serum and tissue hormone levels of vaginally and orally administered estradiol","volume":"180","author":"Tourgeman","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2014.12.004_bb0025","series-title":"Mucoadhesive Materials and Drug Delivery Systems","first-page":"99","article-title":"Vaginal mucosa and drug delivery","author":"das Neves","year":"2014"},{"key":"10.1016\/j.addr.2014.12.004_bb0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13346-011-0024-4","article-title":"Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections","volume":"1","author":"Friend","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0035","first-page":"62","article-title":"State of the art in intravaginal ring technology for topical prophylaxis of HIV infection","volume":"14","author":"Kiser","year":"2012","journal-title":"AIDS Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0169-409X(01)00115-6","article-title":"Drug transfer through mucus","volume":"48","author":"Khanvilkar","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000321047","article-title":"Antimicrobial topical agents used in the vagina","volume":"40","author":"Frey Tirri","year":"2011","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.addr.2014.12.004_bb0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/LGT.0b013e31823da7fb","article-title":"Management of vaginal intraepithelial neoplasia","volume":"16","author":"Gurumurthy","year":"2012","journal-title":"J. Low Genit. Tract Dis."},{"key":"10.1016\/j.addr.2014.12.004_bb0055","doi-asserted-by":"crossref","first-page":"83101","DOI":"10.1063\/1.2973188","article-title":"A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding","volume":"20","author":"Szeri","year":"2008","journal-title":"Phys. Fluids"},{"key":"10.1016\/j.addr.2014.12.004_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2014.12.004_bb0065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.addr.2009.11.017","article-title":"Nanotechnology-based systems for the treatment and prevention of HIV\/AIDS","volume":"62","author":"das Neves","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0070","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.addr.2009.11.022","article-title":"Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV\/AIDS","volume":"62","author":"du Toit","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/17425240903338055","article-title":"Nanoparticle-based vaginal drug delivery systems for HIV prevention","volume":"7","author":"Mallipeddi","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2014.12.004_bb0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/nnm.10.1","article-title":"Emerging nanotechnology approaches for HIV\/AIDS treatment and prevention","volume":"5","author":"Mamo","year":"2010","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.addr.2014.12.004_bb0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/OLQ.0b013e3181bc0aac","article-title":"Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study","volume":"37","author":"O'Loughlin","year":"2010","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.addr.2014.12.004_bb0090","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/QAD.0b013e328346bd3e","article-title":"Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)","volume":"25","author":"McGowan","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2014.12.004_bb0095","doi-asserted-by":"crossref","first-page":"e24095","DOI":"10.1371\/journal.pone.0024095","article-title":"SPL7013 Gel (VivaGel(R)) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans","volume":"6","author":"Price","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.12.004_bb0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/QAI.0b013e31823f2aeb","article-title":"Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety","volume":"59","author":"Moscicki","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.addr.2014.12.004_bb0105","doi-asserted-by":"crossref","first-page":"e12309","DOI":"10.1371\/journal.pone.0012309","article-title":"Structure activity relationship of dendrimer microbicides with dual action antiviral activity","volume":"5","author":"Tyssen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.12.004_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.03.186","article-title":"Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1","volume":"90","author":"Telwatte","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-3155-8-15","article-title":"PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture","volume":"8","author":"Lara","year":"2010","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2014.12.004_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1477-3155-9-38","article-title":"Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins","volume":"9","author":"Lara","year":"2011","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2014.12.004_bb0125","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/bc200663r","article-title":"Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides","volume":"23","author":"Arnaiz","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2014.12.004_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejps.2013.04.035","article-title":"Nanopharmaceuticals for improved topical vaginal therapy: can they deliver?","volume":"50","author":"Vani\u0107","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2014.12.004_bb0135","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","article-title":"Nanoparticle-based drug delivery to the vagina: a review","volume":"190","author":"Ensign","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2014.12.004_bb0140","series-title":"Drug Delivery and Development of Anti-HIV Microbicides","first-page":"415","article-title":"Nanotechnology-based systems for microbicide development","author":"Nunes","year":"2014"},{"key":"10.1016\/j.addr.2014.12.004_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425247.2014.924499","article-title":"Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development","volume":"11","author":"Wong","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2014.12.004_bb0150","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.2147\/IJN.S31757","article-title":"pH and temperature dual-sensitive liposome gel based on novel cleavable mPEG-Hz-CHEMS polymeric vaginal delivery system","volume":"7","author":"Chen","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2014.12.004_bb0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejps.2012.06.001","article-title":"Post-expansile hydrogel foam aerosol of PG-liposomes: a novel delivery system for vaginal drug delivery applications","volume":"47","author":"Li","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2014.12.004_bb0160","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3109\/03639045.2012.707204","article-title":"Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal","volume":"39","author":"Karimunnisa","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/08982104.2013.826242","article-title":"Novel vaginal drug delivery system: deformable propylene glycol liposomes-in-hydrogel","volume":"24","author":"Vani\u0107","year":"2014","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijpharm.2014.06.016","article-title":"Chitosan-coated liposomes for topical vaginal therapy: Assuring localized drug effect","volume":"472","author":"J\u00f8raholmen","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0175","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1002\/jps.22529","article-title":"Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention","volume":"100","author":"Alukda","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2014.12.004_bb0180","first-page":"653","article-title":"Preparation and in vitro anti-tumor properties of toad venom extract-loaded solid lipid nanoparticles","volume":"68","author":"Zhang","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.addr.2014.12.004_bb0185","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.msec.2012.09.007","article-title":"Clotrimazole nanoparticle gel for mucosal administration","volume":"33","author":"Esposito","year":"2013","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2014.12.004_bb0190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3851\/IMP2346","article-title":"Cytolytic nanoparticles attenuate HIV-1 infectivity","volume":"18","author":"Hood","year":"2013","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.addr.2014.12.004_bb0195","doi-asserted-by":"crossref","first-page":"e95411","DOI":"10.1371\/journal.pone.0095411","article-title":"Nanoparticle incorporation of melittin reduces sperm and vaginal epithelium cytotoxicity","volume":"9","author":"Jallouk","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.12.004_bb0200","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1039\/C2CS35265F","article-title":"Design, functionalization strategies and biomedical applications of targeted biodegradable\/biocompatible polymer-based nanocarriers for drug delivery","volume":"42","author":"Nicolas","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0205","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","article-title":"Dendrimer biocompatibility and toxicity","volume":"57","author":"Duncan","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0210","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1002\/anie.200900441","article-title":"Nanogels as pharmaceutical carriers: finite networks of infinite capabilities","volume":"48","author":"Kabanov","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2014.12.004_bb0215","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/pat.1813","article-title":"Biomedical applications of nanofibers","volume":"22","author":"Leung","year":"2011","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.addr.2014.12.004_bb0220","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2009"},{"key":"10.1016\/j.addr.2014.12.004_bb0230","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/1091581811423582","article-title":"Trends in excipient safety evaluation","volume":"30","author":"Osterberg","year":"2011","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.addr.2014.12.004_bb0235","series-title":"Drug Delivery and Development of Anti-HIV Microbicides","first-page":"535","article-title":"Microbicide formulation development: scale-up, affordability, and intellectual property issues","author":"Friend","year":"2014"},{"key":"10.1016\/j.addr.2014.12.004_bb0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2014.12.004_bb0245","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/humrep\/16.9.1809","article-title":"Origins of vaginal acidity: high D\/L lactate ratio is consistent with bacteria being the primary source","volume":"16","author":"Boskey","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.addr.2014.12.004_bb0250","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cocis.2005.11.001","article-title":"Mucin structure, aggregation, physiological functions and biomedical applications","volume":"11","author":"Bansil","year":"2006","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2014.12.004_bb0255","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","article-title":"Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses","volume":"107","author":"Lai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2014.12.004_bb0260","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/wnan.144","article-title":"Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?","volume":"3","author":"das Neves","year":"2011","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2014.12.004_bb0265","series-title":"Pharmaceutical Manufacturing Handbook: Production and Processes","first-page":"809","article-title":"Vaginal drug delivery","author":"das Neves","year":"2008"},{"key":"10.1016\/j.addr.2014.12.004_bb0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2004.06.001","article-title":"Real-time multiple-particle tracking: applications to drug and gene delivery","volume":"57","author":"Suh","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0275","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2014.12.004_bb0280","doi-asserted-by":"crossref","first-page":"e4294","DOI":"10.1371\/journal.pone.0004294","article-title":"Altering mucus rheology to \"solidify\" human mucus at the nanoscale","volume":"4","author":"Lai","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.12.004_bb0285","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.addr.2004.03.001","article-title":"Nanoscale technology of mucoadhesive interactions","volume":"56","author":"Peppas","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0290","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/17425247.2011.586334","article-title":"Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale","volume":"8","author":"das Neves","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2014.12.004_bb0295","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.addr.2014.12.004_bb0300","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2014.07.045","article-title":"Nanoparticle penetration of human cervicovaginal mucus: The effect of polyvinyl alcohol","volume":"192C","author":"Yang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2014.12.004_bb0305","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1021\/la050779w","article-title":"Porcine gastric mucin (PGM) at the water\/poly(dimethylsiloxane) (PDMS) interface: influence of pH and ionic strength on its conformation, adsorption, and aqueous lubrication properties","volume":"21","author":"Lee","year":"2005","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2014.12.004_bb0310","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1021\/mp300408m","article-title":"Interactions of microbicide nanoparticles with a simulated vaginal fluid","volume":"9","author":"das Neves","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0315","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/mp100242r","article-title":"Disruption of the mucus barrier by topically applied exogenous particles","volume":"7","author":"McGill","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0320","doi-asserted-by":"crossref","first-page":"e21547","DOI":"10.1371\/journal.pone.0021547","article-title":"Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.12.004_bb0325","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1021\/bm900344q","article-title":"Movements of HIV-virions in human cervical mucus","volume":"10","author":"Boukari","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2014.12.004_bb0330","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fimmu.2013.00310","article-title":"The influence of mucus microstructure and rheology in infection","volume":"4","author":"Bansil","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2014.12.004_bb0335","doi-asserted-by":"crossref","first-page":"11196","DOI":"10.1128\/JVI.01899-08","article-title":"Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus","volume":"83","author":"Lai","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2014.12.004_bb0340","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1128\/JVI.01377-13","article-title":"Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract","volume":"87","author":"Carias","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2014.12.004_bb0345","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/mi.2012.87","article-title":"Human cervicovaginal mucus contains an activity that hinders HIV-1 movement","volume":"6","author":"Shukair","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2014.12.004_bb0350","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0355","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2014.12.004_bb0360","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s13346-011-0048-9","article-title":"Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-glycolic acid)","volume":"2","author":"Yu","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0365","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/anie.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"50","author":"Yang","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2014.12.004_bb0370","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2011.08.032","article-title":"A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles","volume":"157","author":"Mert","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2014.12.004_bb0375","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \"slip\" through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2014.12.004_bb0380","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/mp8001254","article-title":"Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus","volume":"6","author":"Cu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0385","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/mp400087y","article-title":"Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues","volume":"10","author":"Ensign","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0390","doi-asserted-by":"crossref","first-page":"138ra179","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2014.12.004_bb0395","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.biomaterials.2013.05.039","article-title":"Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake","volume":"34","author":"Ensign","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.12.004_bb0400","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/adhm.201300519","article-title":"Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth","volume":"3","author":"Yang","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2014.12.004_bb0405","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2011.06.036","article-title":"In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery","volume":"156","author":"Cu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2014.12.004_bb0410","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2011.02.002","article-title":"Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system","volume":"155","author":"Wu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2014.12.004_bb0415","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nmat2444","article-title":"Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA","volume":"8","author":"Woodrow","year":"2009","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2014.12.004_bb0420","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1007\/s11095-013-1287-x","article-title":"Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice","volume":"31","author":"das Neves","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0425","doi-asserted-by":"crossref","first-page":"e51995","DOI":"10.1371\/journal.pone.0051995","article-title":"Nanoparticle transport from mouse vagina to adjacent lymph nodes","volume":"7","author":"Ballou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.12.004_bb0430","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cis.2013.06.002","article-title":"Convective diffusion of nanoparticles from the epithelial barrier toward regional lymph nodes","volume":"199\u2013200","author":"Dukhin","year":"2013","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.addr.2014.12.004_bb0435","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/mp4002365","article-title":"In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine","volume":"10","author":"das Neves","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0440","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11095-008-9765-2","article-title":"Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles","volume":"26","author":"Ham","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0445","first-page":"S48","article-title":"Localization of biodegradable nanoparticles in the uterus following intravaginal instillation suggests a novel mode of contraception","volume":"2","author":"Misra","year":"2008","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.addr.2014.12.004_bb0450","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1166\/jbn.2011.1194","article-title":"Biodegradable nanoparticles in the murine vagina: trans-cervical retrograde transport and induction of proinflammatory cytokines","volume":"7","author":"Malik","year":"2011","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.addr.2014.12.004_bb0455","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/infdis\/jir841","article-title":"Distribution of cell-free and cell-associated HIV surrogates in the female genital tract after simulated vaginal intercourse","volume":"205","author":"Louissaint","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2014.12.004_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1389.032","article-title":"Physiology of upward transport in the human female genital tract","volume":"1101","author":"Zervomanolakis","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2014.12.004_bb0465","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1023\/A:1012113714552","article-title":"Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy","volume":"14","author":"Brown","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0470","doi-asserted-by":"crossref","first-page":"a007385","DOI":"10.1101\/cshperspect.a007385","article-title":"Microbicides: topical prevention against HIV","volume":"2","author":"Shattock","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.addr.2014.12.004_bb0475","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.addr.2014.12.004_bb0480","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/sti.2006.021410","article-title":"How, not just if, condoms are used: the timing of condom application and removal during vaginal sex among young people in England","volume":"83","author":"Hatherall","year":"2007","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.addr.2014.12.004_bb0485","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2014.12.004_bb0490","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/QAD.0000000000000156","article-title":"Changes in renal function associated with oral emtricitabine\/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis","volume":"28","author":"Solomon","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2014.12.004_bb0495","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1517\/17425247.2014.888055","article-title":"Vaginal microbicides and their delivery platforms","volume":"11","author":"D'Cruz","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2014.12.004_bb0500","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejps.2011.06.007","article-title":"Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion","volume":"44","author":"Meng","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2014.12.004_bb0505","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2217\/nnm.13.136","article-title":"Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention","volume":"9","author":"Meng","year":"2014","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.addr.2014.12.004_bb0510","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejps.2007.11.004","article-title":"Chitosan citrate as multifunctional polymer for vaginal delivery: Evaluation of penetration enhancement and peptidase inhibition properties","volume":"33","author":"Bonferoni","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2014.12.004_bb0515","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.addr.2012.10.010","article-title":"Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2014.12.004_bb0520","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/600867","article-title":"Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety","volume":"200","author":"Mesquita","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2014.12.004_bb0525","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2011.06.007","article-title":"pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission","volume":"79","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0530","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2010.10.032","article-title":"pH-sensitive Eudragit nanoparticles for mucosal drug delivery","volume":"403","author":"Yoo","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0535","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1208\/s12248-013-9546-7","article-title":"Hyaluronidase-sensitive nanoparticle templates for triggered release of HIV\/AIDS microbicide in vitro","volume":"16","author":"Agrahari","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2014.12.004_bb0540","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1208\/s12248-010-9177-1","article-title":"Near-infrared investigations of novel anti-HIV tenofovir liposomes","volume":"12","author":"Zidan","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2014.12.004_bb0545","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/157016212799304706","article-title":"Will integrase inhibitors be used as microbicides?","volume":"10","author":"Crucitti","year":"2012","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0550","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/157016212799304607","article-title":"Potential use of protease inhibitors as vaginal and colorectal microbicides","volume":"10","author":"Herrera","year":"2012","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0555","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/157016212799304643","article-title":"Reverse transcriptase inhibitors as microbicides","volume":"10","author":"Lewi","year":"2012","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0565","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1128\/AAC.48.10.3684-3689.2004","article-title":"A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides","volume":"48","author":"Van Herrewege","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2014.12.004_bb0570","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1021\/jm040840e","article-title":"In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine)","volume":"48","author":"Janssen","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2014.12.004_bb0575","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s11095-011-0622-3","article-title":"Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine","volume":"29","author":"das Neves","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0580","series-title":"Precise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicides","author":"das Neves","year":"2015"},{"key":"10.1016\/j.addr.2014.12.004_bb0585","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2013.08.049","article-title":"Assessing the physical-chemical properties and stability of dapivirine-loaded polymeric nanoparticles","volume":"456","author":"das Neves","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0590","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jchromb.2012.10.034","article-title":"Development and validation of a HPLC method for the assay of dapivirine in cell-based and tissue permeability experiments","volume":"911","author":"das Neves","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.addr.2014.12.004_bb0595","series-title":"CROI 2014 \u2013 Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA","article-title":"Safety and pharmacokinetics\/pharmacodynamics of dapivirine and maraviroc vaginal rings","author":"Chen","year":"2014"},{"key":"10.1016\/j.addr.2014.12.004_bb0600","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/157016212799304652","article-title":"Combination of antiretroviral drugs as microbicides","volume":"10","author":"Balzarini","year":"2012","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0605","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.antiviral.2012.09.015","article-title":"Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis","volume":"96","author":"Date","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0610","doi-asserted-by":"crossref","first-page":"e61416","DOI":"10.1371\/journal.pone.0061416","article-title":"Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis","volume":"8","author":"Chaowanachan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.12.004_bb0615","first-page":"2847","article-title":"Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4(+) immune cells","volume":"8","author":"Yang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2014.12.004_bb0620","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.antiviral.2010.09.006","article-title":"Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines","volume":"88","author":"Whaley","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0625","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.antiviral.2013.09.027","article-title":"Antibody-based concepts for multipurpose prevention technologies","volume":"100","author":"Whaley","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0630","series-title":"Mucosal Delivery of Biopharmaceuticals","first-page":"261","article-title":"Vaginal delivery of biopharmaceuticals","author":"das Neves","year":"2014"},{"key":"10.1016\/j.addr.2014.12.004_bb0635","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.antiviral.2013.09.022","article-title":"Electrospun fibers for vaginal anti-HIV drug delivery","volume":"100","author":"Blakney","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0640","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.biomaterials.2011.10.004","article-title":"Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery","volume":"33","author":"Huang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2014.12.004_bb0645","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2334-1-17","article-title":"Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120","volume":"1","author":"Neurath","year":"2001","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.addr.2014.12.004_bb0650","doi-asserted-by":"crossref","first-page":"e49792","DOI":"10.1371\/journal.pone.0049792","article-title":"Drug-eluting fibers for HIV-1 inhibition and contraception","volume":"7","author":"Ball","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2014.12.004_bb0655","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2147\/IJN.S61664","article-title":"Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures","volume":"9","author":"Blakney","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2014.12.004_bb0660","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijpharm.2014.08.039","article-title":"Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery","volume":"475","author":"Krogstad","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0665","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/AAC.02564-14","article-title":"Electrospun solid dispersions of maraviroc for rapid intravaginal preexposure prophylaxis of HIV","volume":"58","author":"Ball","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2014.12.004_bb0670","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2165\/00003495-200868130-00002","article-title":"Local treatment of vulvovaginal candidosis: general and practical considerations","volume":"68","author":"das Neves","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2014.12.004_bb0675","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.msec.2012.12.040","article-title":"Clotrimazole-loaded Eudragit\u00ae RS100 nanocapsules: Preparation, characterization and in vitro evaluation of antifungal activity against Candida species","volume":"33","author":"Santos","year":"2013","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2014.12.004_bb0680","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.colsurfb.2014.01.011","article-title":"Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole","volume":"116C","author":"Santos","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2014.12.004_bb0685","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s13346-011-0038-y","article-title":"Prevention of K-Ras- and Pten-mediated intravaginal tumors by treatment with camptothecin-loaded PLGA nanoparticles","volume":"1","author":"Blum","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.addr.2014.12.004_bb0690","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2012.12.023","article-title":"Advancements in the field of intravaginal siRNA delivery","volume":"167","author":"Yang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2014.12.004_bb0695","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature04263","article-title":"An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection","volume":"439","author":"Palliser","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.addr.2014.12.004_bb0700","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chom.2008.12.003","article-title":"Durable protection from Herpes Simplex Virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene","volume":"5","author":"Wu","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.addr.2014.12.004_bb0705","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1172\/JCI45876","article-title":"Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras","volume":"121","author":"Wheeler","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2014.12.004_bb0710","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.4081\/idr.2011.2370","article-title":"Nanoparticles containing siRNA to silence CD4 and CCR5 reduce expression of these receptors and inhibit HIV-1 infection in human female reproductive tract tissue explants","volume":"3","author":"Eszterhas","year":"2011","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.addr.2014.12.004_bb0715","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2012.06.008","article-title":"Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection","volume":"162","author":"Steinbach","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2014.12.004_bb0720","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(07)61908-4","article-title":"Genital herpes","volume":"370","author":"Gupta","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2014.12.004_bb0725","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/322047","article-title":"The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission","volume":"184","author":"Fichorova","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2014.12.004_bb0730","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nm1598","article-title":"Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan","volume":"13","author":"Roberts","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2014.12.004_bb0735","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2014.12.004_bb0740","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1096-9071(199812)56:4<327::AID-JMV7>3.0.CO;2-A","article-title":"Concanavalin A-immobilized polystyrene nanospheres capture HIV-1 virions and gp120: potential approach towards prevention of viral transmission","volume":"56","author":"Hayakawa","year":"1998","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.addr.2014.12.004_bb0745","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jmv.2144","article-title":"Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice","volume":"66","author":"Kawamura","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.addr.2014.12.004_bb0750","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jmv.10279","article-title":"Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice","volume":"69","author":"Akagi","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.addr.2014.12.004_bb0755","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jmv.20100","article-title":"Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques","volume":"73","author":"Miyake","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.addr.2014.12.004_bb0760","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jmv.20317","article-title":"Induction of dendritic cell-mediated immune responses against HIV-1 by antigen-capturing nanospheres in mice","volume":"76","author":"Kawamura","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.addr.2014.12.004_bb0765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.03.012","article-title":"Gels as vaginal drug delivery systems","volume":"318","author":"das Neves","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2014.12.004_bb0770","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/156720109787048294","article-title":"Rheological properties of vaginal hydrophilic polymer gels","volume":"6","author":"das Neves","year":"2009","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.addr.2014.12.004_bb0775","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.contraception.2006.09.003","article-title":"Fourteen-day safety and acceptability study of the universal placebo gel","volume":"75","author":"Schwartz","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2014.12.004_bb0780","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2012.10.018","article-title":"DNA nanotherapy for pre-neoplastic cervical lesions","volume":"128","author":"Peng","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.addr.2014.12.004_bb0785","first-page":"3151","article-title":"Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery","volume":"9","author":"Frank","year":"2014","journal-title":"Int. J. Nanomedicine"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X14003093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X14003093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:35:15Z","timestamp":1759206915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X14003093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":155,"alternative-id":["S0169409X14003093"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2014.12.004","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymer-based nanocarriers for vaginal drug delivery","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2014.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}